Integer Holdings Corp

  • Health Care
  • Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • www.integer.net
  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $4.02B
  • PE 52
  • Debt $1.26B
  • Cash $31.71M
  • EV $5.25B
  • FCF $111.74M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings$76.90M
EBIT$218.51M
ROE5%
ROA7%
FCF$111.74M
Equity$1.61B
Growth Stability70%
PE52.3
PEG11.39
PB2.5
P/FCF36
P/S2.31
Price/Cash0.01
Debt/Equity0.79
Debt/FCF11.29
Net Margins-5%
Gross Margins27%
Op. Margins13%
Earnings CAGR8%
Sales Growth YoY5%
Sales Growth QoQ-3%
Sales CAGR3%
FCF CAGR-4%
Equity CAGR10%
Earnings Stability0.11
Earnings Growth YoY-210%
Earnings Growth QoQ-169%
Earnings CAGR 5Y5%
Sales CAGR 5Y14%
FCF CAGR 5Y-9%
Equity CAGR 5Y6%
Earnings CAGR 3Y12%
Sales CAGR 3Y12%
FCF CAGR 3Y48%
Equity CAGR 3Y7%
Market Cap$4.02B
Revenue$1.74B
Assets$3.30B
Total Debt$1.26B
Cash$31.71M
Shares Outstanding33.92M
EV5.25B
Earnings Score8%
Moat Score50%
Safety Score72%
Final Score43%
Working Capital495.8M
Current Ratio3.4
Gross Profit$469.49M
Shares Growth 3y1%
Equity Growth QoQ-1%
Equity Growth YoY5%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Integer Holdings is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.

SEC Filings

Direct access to Integer Holdings Corp (ITGR) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2025
    • 10-Q Mar 28
  • 2024
    • 10-K Dec 31
    • 10-Q Sep 27
    • 10-Q Jun 28
    • 10-Q Mar 29
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 29
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Integer Holdings Corp compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Integer Holdings Corp compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 8%
Stability 11%
loading chart...

Integer Holdings Corp Discounted Cash Flow

Fully customizable DCF calculator online for Integer Holdings Corp.

= $842M
012345678910TV
fcf$112M$107M$102M$98M$94M$90M$86M$82M$79M$76M$72M$724M
DCF$97M$85M$74M$64M$56M$49M$42M$37M$32M$28M$279M
Value$842M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Net Margins-1%0%5%14%8%7%8%5%6%7%-5%
ROA-4%5%7%7%5%5%4%6%7%7%
ROE-1%7%16%8%6%7%5%6%7%5%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Debt over FCF-37.5616.077.877.275.728.1722.7916.1610.1311.29
Debt over Equity2.12.431.840.910.740.60.620.670.640.620.79
Growth Stability---100%100%70%85%74%100%100%70%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024CAGR 5Y
Revenue YoY growth-73%5%-17%4%-15%14%13%16%8%14%
Earnings YoY growth--178%1K%152%-43%-20%25%-31%37%32%5%
Equity YoY growth--15%23%19%9%10%7%5%7%7%6%
FCF YoY growth--246%118%20%-4%15%-23%-60%45%66%-9%